Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
AIMS: Long QT syndrome 2 (LQTS2) caused by missense mutations in hERG channel is clinically associated with abnormally prolonged ventricular repolarization and sudden cardiac deaths. Modelling monogenic arrhythmogenic diseases using human-induced pluripotent stem cells (hiPSCs) offers unprecedented mechanistic insights into disease pathogenesis. We utilized LQTS2-hiPSC-derived cardiomyocytes (CMs) to elucidate pathological changes and to demonstrate reversal of LQTS2 phenotype in a therapeutic intervention using a pharmacological agent, (N-[N-(N-acetyl-l-leucyl)-l-leucyl]-l-norleucine) (ALLN). METHODS AND RESULTS: We generated LQTS2-specific CMs (A561V missense mutation in KCNH2) from iPSCs using the virus-free reprogramming method. These CMs recapitulate dysfunction of hERG potassium channel with diminished IKr currents, prolonged repolarization durations, and elevated arrhythmogenesis due to reduced membrane localization of glycosylated/mature hERG. Dysregulated expression of folding chaperones and processing proteasomes coupled with sequestered hERG in the endoplasmic reticulum confirmed trafficking-induced disease manifestation. Treatment with ALLN, not only increased membrane localization of mature hERG but also reduced repolarization, increased IKr currents and reduced arrhythmogenic events. Diverged from biophysical interference of hERG channel, our results show that modulation of chaperone proteins could be therapeutic in LQTS2 treatment. CONCLUSION: Our in vitro study shows an alternative approach to rescue diseased LQTS2 phenotype via corrective re-trafficking therapy using a small chemical molecule, such as ALLN. This potentially novel approach may have ramifications in other clinically relevant trafficking disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Traditionally, animal models, primary cells, embryonic stem cells (ESC), and immortalized cell lines derived from tumor cells are used to model a variety of human diseases [8,9,10,11].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [8]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [8]
Citations
Cites
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049 · cited 1×
“Disease-specific-induced pluripotent stem cells offer unique opportunity for disease modelling.(10,11) Such models yield previously unavailable insights into the molecular basis of disease manifestations that could serve as an invaluable platform for risk stratification and drug discovery.”
BackgroundLow Penetrance in the Long-QT Syndrome: Clinical Impact
Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.4.529 · Cited by 804
Goldenberg, I., & Moss, A. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.068 · Cited by 651
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Shieh, C.-C., Coghlan, M., Sullivan, J. P., & Gopalakrishnan, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01469-8 · Cited by 518
A Small Molecule Inhibitor of Inducible Heat Shock Protein 70
Leu, J. I.-J., Pimkina, J., Frank, A., Murphy, M. E., & George, D. L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.023 · Cited by 441
Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells
Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I.-H., & Gepstein, L. (2009) · Circulation · doi:10.1161/circulationaha.109.868885 · Cited by 435 · cited 1×
“FPD measurements were normalized (corrected FPD, cFPD) to the beating rate of the contracting areas with the Bazzet correction formula: cFPD 1⁄4 FPD/p(RR interval).(16)”
MethodMost LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism
Anderson, C. L., Delisle, B. P., Anson, B. D., Kilby, J. A., Will, M. L., Tester, D. J., Gong, Q., Zhou, Z., Ackerman, M. J., & January, C. T. (2006) · Circulation · doi:10.1161/circulationaha.105.570200 · Cited by 408
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth, A., & Denning, C. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr073 · Cited by 389
Roden, D. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0706513 · Cited by 380 · cited 2×
“Hereditary long QT syndrome (LQTS) is a genetic disorder caused by mutations in one or more ion channel subunits expressed in the heart.(1,2) LQTS is characterizedby delayed or prolonged cardiac repolarization in the electrocardiogram with increased risks of developing polymorphic ventricular tachycardia (torsade de p…”
BackgroundRole of the Cytosolic Chaperones Hsp70 and Hsp90 in Maturation of the Cardiac Potassium Channel hERG
Ficker, E., Dennis, A. T., Wang, L., & Brown, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000079028.31393.15 · Cited by 323
Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II
Priori, S. G., Barhanin, J., Hauer, R. N. W., Haverkamp, W., Jongsma, H. J., Kleber, A. G., McKenna, W. J., Roden, D. M., Rudy, Y., Schwartz, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.4.518 · Cited by 294
Losing heart: the role of apoptosis in heart disease—a novel therapeutic target?
Gill, C., Mestril, R., & Samali, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0629com · Cited by 289
Lahti, A. L., Kujala, V. J., Chapman, H., Koivisto, A.-P., Pekkanen-Mattila, M., Kerkelä, E., Hyttinen, J., Kontula, K., Swan, H., Conklin, B. R., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008409 · Cited by 288
Calpains, mitochondria, and apoptosis
Smith, M. A., & Schnellmann, R. G. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs163 · Cited by 248
Bellin, M., Casini, S., Davis, R. P., D'Aniello, C., Haas, J., Ward-van Oostwaard, D., Tertoolen, L. G. J., Jung, C. B., Elliott, D. A., Welling, A., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.240 · Cited by 196 · cited 3×
“While this paper was under revision, Bellin et al.34 demonstrated that proteosomal inhibitor lactacystin augmented the level of mature hERG in NKx2.”
BackgroundInfluentialCalpain 3, the “gatekeeper” of proper sarcomere assembly, turnover and maintenance
Beckmann, J. S., & Spencer, M. J. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.08.005 · Cited by 178
Regulation and physiological roles of the calpain system in muscular disorders
Sorimachi, H., & Ono, Y. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs157 · Cited by 140
Matsa, E., Dixon, J. E., Medway, C., Georgiou, O., Patel, M. J., Morgan, K., Kemp, P. J., Staniforth, A., Mellor, I., & Denning, C. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht067 · Cited by 126 · cited 2×
“Recently, Matsa et al.(29) demonstrated that modulating mutant allele by specific siRNA may help to relieve LQTS2 in vitro.”
BackgroundFicker, E. K., Dennis, A. T., Obejero‐Paz, C. A., Castaldo, P., Taglialatela, M., & Brown, A. M. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1263 · Cited by 105
The Dominant Negative LQT2 Mutation A561V Reduces Wild-type HERG Expression
Kagan, A., Yu, Z., Fishman, G. I., & McDonald, T. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11241 · Cited by 99 · cited 2×
“As trafficking was implicated in our results, we treated the LQTS2-CMs with 10 mM ALLN (N-[N-(N-acetyl-L-leucyl)-L-leucyl]-L-norleucine; C20H37N3O4), a known calpain 1/2 and proteasome inhibitor, which had previously shown to rescue overexpressed mutated hERG in HEK heterologous systems.(9) Post-ALLN treatment (42 h),…”
MethodResultThomas, D., Kiehn, J., Katus, H. A., & Karle, C. A. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.08.002 · Cited by 97
Mehta, A. K., Chung, Y. Y., Ng, A., Iskandar, F., Atan, S., Wei, H., Dusting, G. J., Sun, W. Y., Wong, P., & SHIM, W. S. N. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr132 · Cited by 95 · cited 4×
“Approximately 1 × 10(6) hiPS cells were injected into the kidney capsule as previously described.(13,14) Mice were euthanized with carbon dioxide asphyxiation at 8 weeks after injections and tumours collected, fixed, and processed for standard H&E staining.”
MethodInfluentialSelf-citationA mutation in HERG Associated with Notched T waves in Long QT Syndrome
Dausse, E., Berthet, M., Denjoy, I., André-Fouet, X., Cruaud, C., Bennaceur, M., Fauré, S., Coumel, P., Schwartz, K., & Guicheney, P. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0151 · Cited by 84
Guo, J., Wang, T., Li, X., Shallow, H., Yang, T., Li, W., Xu, J., Fridman, M. D., Yang, X., & Zhang, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.389643 · Cited by 69
Pharmacoelectrophysiology of Viral-Free Induced Pluripotent Stem Cell–Derived Human Cardiomyocytes
Mehta, A. K., Chung, Y. Y., Sequiera, G. L., Wong, P., Liew, R., & SHIM, W. S. N. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs309 · Cited by 57 · cited 1×
“To characterize the electrophysiological properties of the hiPS-CMs, a microelectrode array (MEA) recording system (Multichannel Systems, Reutlingen, Germany) was used as described previously.(13,15) Briefly, contracting areas were micro-dissected and plated on MEA plates, allowed to adjust for 72 h before recording.”
MethodSelf-citationA Common Antitussive Drug, Clobutinol, Precipitates the Long QT Syndrome 2
Bellocq, C., Wilders, R., Schott, J., Louërat-Oriou, B., Boisseau, P., Marec, H. L., Escande, D., & Baró, I. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001065 · Cited by 55
Pharmacological approach to the treatment of long and short QT syndromes
Patel, C., & Antzelevitch, C. N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.001 · Cited by 53 · cited 1×
“Contracting EBs from control and LQTS2 were also evaluated with drugs that may ameliorate or aggravate the disease phenotype.(18)”
MethodPathophysiology of ion channel mutations
Keating, M. T., & Sanguinetti, M. C. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80010-4 · Cited by 46 · cited 1×
“Hereditary long QT syndrome (LQTS) is a genetic disorder caused by mutations in one or more ion channel subunits expressed in the heart.(1,2) LQTS is characterizedby delayed or prolonged cardiac repolarization in the electrocardiogram with increased risks of developing polymorphic ventricular tachycardia (torsade de p…”
BackgroundIwai, C., Li, P., Kurata, Y., Hoshikawa, Y., Morikawa, K., Maharani, N., Higaki, K., Sasano, T., Notsu, T., Ishido, Y., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt200 · Cited by 38 · cited 1×
“Indeed, changes in HSP70/90 relationship and associated ubiquitination in channel maturation of hERG mutants have been previously demonstrated.(35) This together with decreased CAV3-mediated hERG turnover resulted in an increased sarcolemmal hERG and may result in an increased retention of glycosylated hERG as shown b…”
BackgroundFate Mapping of Human Embryonic Stem Cells by Teratoma Formation
Ritner, C., & Bernstein, H. S. (2010) · Journal of Visualized Experiments · doi:10.3791/2036 · Cited by 27 · cited 1×
“Approximately 1 × 10(6) hiPS cells were injected into the kidney capsule as previously described.(13,14) Mice were euthanized with carbon dioxide asphyxiation at 8 weeks after injections and tumours collected, fixed, and processed for standard H&E staining.”
Activation of calpain-1 in human carotid artery atherosclerotic lesions
Gonçalves, I., Nitulescu, M., Saido, T. C., Dias, N. V., Pedro, L. M., Fernandes, J. F. E., Ares, M. P. S., & Pörn-Ares, I. (2009) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-9-26 · Cited by 17
Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation
Ritner, C., & Bernstein, H. S. (2010) · Journal of Visualized Experiments · doi:10.3791/2036-v · Cited by 14
Research works printed but not linked: 2
- Napolitano, 1997, Identification of a mutational hot spot in HERG-related long QT syndrome (LQT2): phenotypic implications, Circulation, 96, I
- Schwartz, 1997, Gene-specific influence on the triggers for cardiac arrest in the long QT syndrome, Circulation, 96, 1
Cited by
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence
Chinen, A. B., Guan, C. M., Ferrer, J. R., Barnaby, S. N., Merkel, T. J., & Mirkin, C. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00321 · Cited by 1,032
Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?
Veerman, C. C., Kosmidis, G., Mummery, C. L., Casini, S., Verkerk, A. O., & Bellin, M. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0533 · Cited by 265
“Methods to distinguish different hPSC-CM subtypes and attribute maturation to these specifically would greatly benefit research [156,157].”
Musunuru, K., Sheikh, F., Gupta, R. M., Houser, S. R., Maher, K. O., Milan, D. J., Terzic, A., & Wu, J. C. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000043 · Cited by 229
Induced pluripotent stem cells: at the heart of cardiovascular precision medicine
Chen, I. Y., Matsa, E., & Wu, J. C. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.36 · Cited by 191
Long QT Syndrome: Genetics and Future Perspective
Wallace, E. J., Howard, L., Liu, M., O’Brien, T., Ward, D., Shen, S., & Prendiville, T. W. (2019) · Pediatric Cardiology · doi:10.1007/s00246-019-02151-x · Cited by 168
“Heterozygote KCNH2 mutations exert a dominant-negative effect on wild-type hERG channel-associated IKr currents by impairing trafficking pathways or altered channel kinetics of the resulting co-assembled hERG heterotetramers [15].”
Background
Metadata
- Authors
- Mehta, A., Sequiera, G. L., Ramachandra, C. J. A., Sudibyo, Y., Chung, Y., Sheng, J., Wong, K. Y., Tan, T. H., Wong, P., Liew, R., & Shim, W.
- Affiliations
- National Heart Centre Singapore (SG)
- KK Women's and Children's Hospital (SG)
- National University of Singapore (SG)
- Corresponding author
- Mehta, Ashish
- Shim, Winston
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-12
- Volume
- 102
- Issue
- 3
- Pages
- 497-506
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W4244933903
- Cited by
- 110
- References
- 35
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 6 · 2021: 11 · 2020: 8 · 2019: 11 · 2018: 6 · 2017: 12 · 2016: 12 · 2015: 17 · 2014: 11
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Duke-NUS Medical School
- National Research Foundation
- National Research Foundation Singapore (NRF‐CRP‐2008‐02)
- Medical Research Council
- National Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- hERG, iPSC-derived cardiomyocytes, ALLN, IKr current, ventricular repolarization, molecular chaperones, proteasome, arrhythmogenesis, disease modeling
- MeSH terms
- ERG1 Potassium Channel, Animals, Humans, Leupeptins, Long QT Syndrome, Male, Mutation, Phenotype, Protein Transport, Myocytes, Cardiac, Mice, Ether-A-Go-Go Potassium Channels, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.